Skip to main content

Chronic Myeloid Leukemia

Rare

Cancer

Chronic Myeloid Leukemia is treated with 24 medications in our database, including dasatinib, YESINTEK, nilotinib, Iclusig, Dasatinib, and 19 more. 17 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Bristol Myers Squibb, Novartis, Takeda, Eton, Aspen and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Chronic Myeloid Leukemia treatment below.

What help exists for Chronic Myeloid Leukemia

22

drugs indexed

18

with copay cards

18

with patient assistance

19

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Chronic Myeloid Leukemia

22 total

🎟 = copay card Β· πŸ’™ = patient assistance program

Prior authorization patterns for Chronic Myeloid Leukemia drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

Showing 10 of 25 PA rules for Chronic Myeloid Leukemia drugs. View individual drug pages for complete PA detail.

Grants for Chronic Myeloid Leukemia patients

30 total Β· 19 open

Chronic Myeloid Leukemia is a rare disease β€” more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare β†’